No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Ethicon Surgical Innovations Lab Kicks Off: Benefits Surgeons Unable to Travel

Editor: What To Know

  • Surgeons will be able to use the various devices on inanimate tissue and engage with key faculty, engineers and researchers on the technical aspects of the products, as well as the body of evidence that supports them.
  • “After a year like no other, we're eager to bring these latest advances directly to surgeons in their own communities and continue building on our trusted legacy of innovation to shape the future of surgery,” said Nefertiti Greene, President, US Ethicon.
  • Johnson Medical Devices Companies**, today announced its state-of-the-art and fully functional surgical lab on wheels will travel to hospitals in 70 locations across America providing surgeons and other healthcare professionals the opportunity for hands-on learning experiences and demonstrations with the newest technologies for colorectal, bariatric, gynecological and thoracic procedures.

Ethicon*, part of the Johnson & Johnson Medical Devices Companies**, today announced its state-of-the-art and fully functional surgical lab on wheels will travel to hospitals in 70 locations across America providing surgeons and other healthcare professionals the opportunity for hands-on learning experiences and demonstrations with the newest technologies for colorectal, bariatric, gynecological and thoracic procedures.

ethicon

The Ethicon Surgical Innovations Lab will showcase the company’s portfolio of advanced energy solutions including the recently launched ENSEAL X1 Curved Jaw Tissue Sealer, which continuously senses changes in tissue and responds with the optimized amount of energy during surgery.[i]

The groundbreaking ECHELON CIRCULAR Powered Stapler will also be among the surgical stapler technology featured on the more than 850-square-foot mobile lab. In recent studies, the ECHELON CIRCULAR, which is the world’s first circular powered stapler, has been shown to reduce anastomotic leaks, a relatively common and potentially life-threatening complication of colorectal surgery, by nearly 74% compared to manual circular staplers.[ii] Surgical staplers utilize specialized staples to close off and cut through organs, tissue and blood vessels in both laparoscopic and traditional surgery.

“After a year like no other, we’re eager to bring these latest advances directly to surgeons in their own communities and continue building on our trusted legacy of innovation to shape the future of surgery,” said Nefertiti Greene, President, US Ethicon. “Ethicon has a significant research, development and educational focus on improving patient outcomes, reducing life-threatening and costly complications, and streamlining surgery through innovations in surgical stapling technology and energy-based devices.”

Over the last year, the COVID-19 pandemic has limited opportunities for surgeons and other practitioners to travel for in-person learning experiences. The Ethicon Surgical Innovations Lab mobile tour is being conducted to help surgeons and hospitals stay current on the latest technologies and the science behind them from the convenience of their own cities. Surgeons will be able to use the various devices on inanimate tissue and engage with key faculty, engineers and researchers on the technical aspects of the products, as well as the body of evidence that supports them.

The Ethicon Surgical Innovation Lab was recently in Dayton, Ohio at Kettering Health for one of its first stops on the national tour.

“The mobile lab was an amazing experience. The benefit for our surgeons and staff to be able to get hands-on training and education cannot be measured. I encourage anyone who has the opportunity to visit the lab to definitely do so. We walked away with very valuable knowledge and understanding of the new technology being offered. Definitely a must see for clinicians and staff,” said Jerry Willis, Strategic Sourcing Manager Surgical Services, Kettering Health.

[i]Claim #134168-210203

[ii]Sylla, P., Sagar, P., Johnston, S.S. et al. Outcomes associated with the use of a new powered circular stapler for left-sided colorectal reconstructions: a propensity score matching-adjusted indirect comparison with manual circular staplers. Surg Endosc(2021). https://doi.org/10.1007/s00464-021-08542-7


[1]Claim #134168-210203

[1]Sylla, P., Sagar, P., Johnston, S.S. et al. Outcomes associated with the use of a new powered circular stapler for left-sided colorectal reconstructions: a propensity score matching-adjusted indirect comparison with manual circular staplers. Surg Endosc(2021). https://doi.org/10.1007/s00464-021-08542-7

*Ethicon represents the products and services of Ethicon, Inc., Ethicon Endo-Surgery, LLC and certain of their affiliates. All other trademarks are the property of their respective owners.

**The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopedics, and interventional solutions businesses within Johnson & Johnson’s Medical Devices segment.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy